Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 21;3(1):fcaa235.
doi: 10.1093/braincomms/fcaa235. eCollection 2021.

Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain

Affiliations

Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain

Zimeng Ye et al. Brain Commun. .

Erratum in

Abstract

Brain somatic mutations are an increasingly recognized cause of epilepsy, brain malformations and autism spectrum disorders and may be a hidden cause of other neurodevelopmental and neurodegenerative disorders. At present, brain mosaicism can be detected only in the rare situations of autopsy or brain biopsy. Liquid biopsy using cell-free DNA derived from cerebrospinal fluid has detected somatic mutations in malignant brain tumours. Here, we asked if cerebrospinal fluid liquid biopsy can be used to detect somatic mosaicism in non-malignant brain diseases. First, we reliably quantified cerebrospinal fluid cell-free DNA in 28 patients with focal epilepsy and 28 controls using droplet digital PCR. Then, in three patients we identified somatic mutations in cerebrospinal fluid: in one patient with subcortical band heterotopia the LIS1 p. Lys64* variant at 9.4% frequency; in a second patient with focal cortical dysplasia the TSC1 p. Phe581His*6 variant at 7.8% frequency; and in a third patient with ganglioglioma the BRAF p. Val600Glu variant at 3.2% frequency. To determine if cerebrospinal fluid cell-free DNA was brain-derived, whole-genome bisulphite sequencing was performed and brain-specific DNA methylation patterns were found to be significantly enriched (P = 0.03). Our proof of principle study shows that cerebrospinal fluid liquid biopsy is valuable in investigating mosaic neurological disorders where brain tissue is unavailable.

Keywords: cell-free DNA; cerebrospinal fluid; focal epilepsy; liquid biopsy; somatic mutations.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Figure 1
Figure 1
ddPCR 2D-plot for molecular diagnosis in CSF from three patients with lesional focal epilepsy. (A). 2D-Plot showing droplets positive (blue, upper left quadrant) for LIS1 Lys64* in patient 1. CSF cell-free DNA was tested twice with similar VAF, then data were combined. Mutant concentration 3.61 copies/μl; wild-type concentration 35 copies/μl; VAF: 9.4%. (B) 2D-plot showing droplets positive for TSC1 p. Phe581His*6 in patient 2. CSF cell-free DNA: mutant concentration 0.47 copies/μl; wild-type concentration 5.58 copies/μl; VAF: 7.8%. (C) 2D-plot showing droplets positive for BRAF Val600Glu in patient 3. CSF cell-free DNA: mutant concentration 0.42 copies/μl; wild-type concentration 12.7 copies/μl; VAF: 3.2%. Green droplets are wild-type copies, orange droplets are double-positive copies and grey droplets are empty. VAF: variant allele frequency.
Figure 2
Figure 2
Enrichment of CNS-derived cell-free DNA in CSF samples. (A) Unique pseudo-alignment of cell-free DNA from CSF and plasma to reference sequences/k-mers from 11 tissues. (B) Unique sequence pseudo-alignments of cell-free DNA from CSF and plasma to brain and blood cells. CSF-derived cell-free DNA has significantly higher number of unique reads pseudo-aligned to brain compared to plasma-derived cell-free DNA (P=0.03), whereas plasma-derived cell-free DNA was significantly enriched for unique reads pseudo-aligned to blood cells (P=0.04).

Similar articles

Cited by

References

    1. Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, et al. De novo mutations in epileptic encephalopathies. Nature 2013; 501: 217–21. - PMC - PubMed
    1. Berghoff AS, Preusser M.. BRAF alterations in brain tumours: molecular pathology and therapeutic opportunities. Curr Opin Neurol 2014; 27: 689–96. - PubMed
    1. Bianchi DW, Chiu RWK.. Sequencing of circulating cell-free DNA during pregnancy. N Engl J Med 2018; 379: 464–73. - PMC - PubMed
    1. Bray NL, Pimentel H, Melsted P, Pachter L.. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol 2016; 34: 525–7. - PubMed
    1. Chandrananda D, Thorne NP, Bahlo M.. High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA. BMC Med Genomics 2015; 8: 29. - PMC - PubMed

LinkOut - more resources